nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—Methylprednisolone—multiple sclerosis	0.0794	0.11	CbGbCtD
Toremifene—CYP1A1—Dexamethasone—multiple sclerosis	0.0769	0.107	CbGbCtD
Toremifene—CYP3A4—Fingolimod—multiple sclerosis	0.0738	0.103	CbGbCtD
Toremifene—ABCB1—Mitoxantrone—multiple sclerosis	0.0579	0.0805	CbGbCtD
Toremifene—ABCB1—Betamethasone—multiple sclerosis	0.0516	0.0718	CbGbCtD
Toremifene—ABCB1—Prednisolone—multiple sclerosis	0.0509	0.0708	CbGbCtD
Toremifene—ABCB1—Prednisone—multiple sclerosis	0.0481	0.0669	CbGbCtD
Toremifene—CYP3A4—Methylprednisolone—multiple sclerosis	0.0476	0.0661	CbGbCtD
Toremifene—CYP3A4—Triamcinolone—multiple sclerosis	0.036	0.0501	CbGbCtD
Toremifene—CYP3A4—Mitoxantrone—multiple sclerosis	0.0347	0.0482	CbGbCtD
Toremifene—CYP3A4—Betamethasone—multiple sclerosis	0.0309	0.043	CbGbCtD
Toremifene—CYP3A4—Prednisolone—multiple sclerosis	0.0305	0.0424	CbGbCtD
Toremifene—ABCB1—Dexamethasone—multiple sclerosis	0.03	0.0417	CbGbCtD
Toremifene—CYP3A4—Prednisone—multiple sclerosis	0.0288	0.0401	CbGbCtD
Toremifene—ABCB1—Methotrexate—multiple sclerosis	0.0241	0.0335	CbGbCtD
Toremifene—CYP3A4—Dexamethasone—multiple sclerosis	0.018	0.025	CbGbCtD
Toremifene—Loperamide—POMC—multiple sclerosis	0.00176	1	CrCbGaD
Toremifene—Breast disorder—Methylprednisolone—multiple sclerosis	0.000707	0.0029	CcSEcCtD
Toremifene—Insomnia—Cladribine—multiple sclerosis	0.000703	0.00288	CcSEcCtD
Toremifene—Affect lability—Dexamethasone—multiple sclerosis	0.0007	0.00287	CcSEcCtD
Toremifene—Affect lability—Betamethasone—multiple sclerosis	0.0007	0.00287	CcSEcCtD
Toremifene—Leukopenia—Azathioprine—multiple sclerosis	0.000693	0.00284	CcSEcCtD
Toremifene—Dyspnoea—Cladribine—multiple sclerosis	0.000693	0.00284	CcSEcCtD
Toremifene—Decreased appetite—Cladribine—multiple sclerosis	0.000676	0.00277	CcSEcCtD
Toremifene—Mood swings—Dexamethasone—multiple sclerosis	0.000674	0.00277	CcSEcCtD
Toremifene—Mood swings—Betamethasone—multiple sclerosis	0.000674	0.00277	CcSEcCtD
Toremifene—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000671	0.00275	CcSEcCtD
Toremifene—Weight increased—Prednisolone—multiple sclerosis	0.000671	0.00275	CcSEcCtD
Toremifene—Fatigue—Cladribine—multiple sclerosis	0.00067	0.00275	CcSEcCtD
Toremifene—Pain—Cladribine—multiple sclerosis	0.000665	0.00273	CcSEcCtD
Toremifene—Constipation—Cladribine—multiple sclerosis	0.000665	0.00273	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000655	0.00269	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000648	0.00266	CcSEcCtD
Toremifene—Chills—Mitoxantrone—multiple sclerosis	0.000645	0.00265	CcSEcCtD
Toremifene—Myocardial infarction—Prednisolone—multiple sclerosis	0.000644	0.00264	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000644	0.00264	CcSEcCtD
Toremifene—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000642	0.00264	CcSEcCtD
Toremifene—Alopecia—Mitoxantrone—multiple sclerosis	0.000635	0.00261	CcSEcCtD
Toremifene—Cardiac failure—Prednisone—multiple sclerosis	0.000635	0.0026	CcSEcCtD
Toremifene—Lethargy—Prednisone—multiple sclerosis	0.000632	0.00259	CcSEcCtD
Toremifene—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000619	0.00254	CcSEcCtD
Toremifene—Weight increased—Triamcinolone—multiple sclerosis	0.000617	0.00253	CcSEcCtD
Toremifene—Weight increased—Methylprednisolone—multiple sclerosis	0.000615	0.00252	CcSEcCtD
Toremifene—Skin disorder—Azathioprine—multiple sclerosis	0.000614	0.00252	CcSEcCtD
Toremifene—Affect lability—Prednisone—multiple sclerosis	0.00061	0.0025	CcSEcCtD
Toremifene—Back pain—Mitoxantrone—multiple sclerosis	0.000606	0.00248	CcSEcCtD
Toremifene—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000598	0.00245	CcSEcCtD
Toremifene—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000596	0.00244	CcSEcCtD
Toremifene—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000594	0.00244	CcSEcCtD
Toremifene—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000592	0.00243	CcSEcCtD
Toremifene—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000592	0.00243	CcSEcCtD
Toremifene—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000591	0.00242	CcSEcCtD
Toremifene—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000591	0.00242	CcSEcCtD
Toremifene—Vision blurred—Mitoxantrone—multiple sclerosis	0.00059	0.00242	CcSEcCtD
Toremifene—Mood swings—Prednisone—multiple sclerosis	0.000587	0.00241	CcSEcCtD
Toremifene—Sweating—Methylprednisolone—multiple sclerosis	0.000578	0.00237	CcSEcCtD
Toremifene—Visual impairment—Prednisolone—multiple sclerosis	0.000569	0.00233	CcSEcCtD
Toremifene—Leukopenia—Mitoxantrone—multiple sclerosis	0.00056	0.0023	CcSEcCtD
Toremifene—Weight increased—Dexamethasone—multiple sclerosis	0.00056	0.0023	CcSEcCtD
Toremifene—Weight increased—Betamethasone—multiple sclerosis	0.00056	0.0023	CcSEcCtD
Toremifene—Asthenia—Cladribine—multiple sclerosis	0.000558	0.00229	CcSEcCtD
Toremifene—Pruritus—Cladribine—multiple sclerosis	0.00055	0.00226	CcSEcCtD
Toremifene—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000546	0.00224	CcSEcCtD
Toremifene—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000541	0.00222	CcSEcCtD
Toremifene—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000541	0.00222	CcSEcCtD
Toremifene—Myocardial infarction—Betamethasone—multiple sclerosis	0.000538	0.00221	CcSEcCtD
Toremifene—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000538	0.00221	CcSEcCtD
Toremifene—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000538	0.00221	CcSEcCtD
Toremifene—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000538	0.00221	CcSEcCtD
Toremifene—Chest pain—Mitoxantrone—multiple sclerosis	0.000533	0.00219	CcSEcCtD
Toremifene—Lethargy—Methotrexate—multiple sclerosis	0.000529	0.00217	CcSEcCtD
Toremifene—Arrhythmia—Prednisolone—multiple sclerosis	0.000527	0.00216	CcSEcCtD
Toremifene—Visual impairment—Methylprednisolone—multiple sclerosis	0.000522	0.00214	CcSEcCtD
Toremifene—Dizziness—Cladribine—multiple sclerosis	0.000514	0.00211	CcSEcCtD
Toremifene—Oedema—Mitoxantrone—multiple sclerosis	0.000511	0.0021	CcSEcCtD
Toremifene—Eye disorder—Methylprednisolone—multiple sclerosis	0.000506	0.00208	CcSEcCtD
Toremifene—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.0005	0.00205	CcSEcCtD
Toremifene—Skin disorder—Mitoxantrone—multiple sclerosis	0.000496	0.00204	CcSEcCtD
Toremifene—Vomiting—Cladribine—multiple sclerosis	0.000494	0.00203	CcSEcCtD
Toremifene—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000494	0.00203	CcSEcCtD
Toremifene—Angiopathy—Methylprednisolone—multiple sclerosis	0.000491	0.00201	CcSEcCtD
Toremifene—Mood swings—Methotrexate—multiple sclerosis	0.000491	0.00201	CcSEcCtD
Toremifene—Rash—Cladribine—multiple sclerosis	0.00049	0.00201	CcSEcCtD
Toremifene—Dermatitis—Cladribine—multiple sclerosis	0.00049	0.00201	CcSEcCtD
Toremifene—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000488	0.002	CcSEcCtD
Toremifene—Weight increased—Prednisone—multiple sclerosis	0.000487	0.002	CcSEcCtD
Toremifene—Anorexia—Mitoxantrone—multiple sclerosis	0.000487	0.002	CcSEcCtD
Toremifene—Ataxia—Methotrexate—multiple sclerosis	0.000487	0.002	CcSEcCtD
Toremifene—Headache—Cladribine—multiple sclerosis	0.000487	0.002	CcSEcCtD
Toremifene—Arrhythmia—Triamcinolone—multiple sclerosis	0.000485	0.00199	CcSEcCtD
Toremifene—Vision blurred—Prednisolone—multiple sclerosis	0.000484	0.00199	CcSEcCtD
Toremifene—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000484	0.00198	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000478	0.00196	CcSEcCtD
Toremifene—Visual impairment—Dexamethasone—multiple sclerosis	0.000474	0.00195	CcSEcCtD
Toremifene—Visual impairment—Betamethasone—multiple sclerosis	0.000474	0.00195	CcSEcCtD
Toremifene—Mental disorder—Methylprednisolone—multiple sclerosis	0.000474	0.00195	CcSEcCtD
Toremifene—Malnutrition—Methylprednisolone—multiple sclerosis	0.000471	0.00193	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000471	0.00193	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000468	0.00192	CcSEcCtD
Toremifene—Myocardial infarction—Prednisone—multiple sclerosis	0.000468	0.00192	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—multiple sclerosis	0.000468	0.00192	CcSEcCtD
Toremifene—Nausea—Cladribine—multiple sclerosis	0.000462	0.00189	CcSEcCtD
Toremifene—Vertigo—Prednisolone—multiple sclerosis	0.000461	0.00189	CcSEcCtD
Toremifene—Eye disorder—Betamethasone—multiple sclerosis	0.00046	0.00189	CcSEcCtD
Toremifene—Eye disorder—Dexamethasone—multiple sclerosis	0.00046	0.00189	CcSEcCtD
Toremifene—Back pain—Triamcinolone—multiple sclerosis	0.000457	0.00187	CcSEcCtD
Toremifene—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000455	0.00187	CcSEcCtD
Toremifene—Angiopathy—Dexamethasone—multiple sclerosis	0.000447	0.00183	CcSEcCtD
Toremifene—Angiopathy—Betamethasone—multiple sclerosis	0.000447	0.00183	CcSEcCtD
Toremifene—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000444	0.00182	CcSEcCtD
Toremifene—Fatigue—Mitoxantrone—multiple sclerosis	0.00044	0.00181	CcSEcCtD
Toremifene—Arrhythmia—Dexamethasone—multiple sclerosis	0.00044	0.0018	CcSEcCtD
Toremifene—Arrhythmia—Betamethasone—multiple sclerosis	0.00044	0.0018	CcSEcCtD
Toremifene—Pain—Mitoxantrone—multiple sclerosis	0.000437	0.00179	CcSEcCtD
Toremifene—Constipation—Mitoxantrone—multiple sclerosis	0.000437	0.00179	CcSEcCtD
Toremifene—Alopecia—Betamethasone—multiple sclerosis	0.000435	0.00178	CcSEcCtD
Toremifene—Alopecia—Dexamethasone—multiple sclerosis	0.000435	0.00178	CcSEcCtD
Toremifene—Vertigo—Triamcinolone—multiple sclerosis	0.000424	0.00174	CcSEcCtD
Toremifene—Vertigo—Methylprednisolone—multiple sclerosis	0.000423	0.00174	CcSEcCtD
Toremifene—Oedema—Prednisolone—multiple sclerosis	0.000419	0.00172	CcSEcCtD
Toremifene—Dizziness—Azathioprine—multiple sclerosis	0.000418	0.00171	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000405	0.00166	CcSEcCtD
Toremifene—Vomiting—Azathioprine—multiple sclerosis	0.000402	0.00165	CcSEcCtD
Toremifene—Eye disorder—Prednisone—multiple sclerosis	0.000401	0.00164	CcSEcCtD
Toremifene—Rash—Azathioprine—multiple sclerosis	0.000398	0.00163	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000398	0.00163	CcSEcCtD
Toremifene—Dermatitis—Azathioprine—multiple sclerosis	0.000398	0.00163	CcSEcCtD
Toremifene—Headache—Azathioprine—multiple sclerosis	0.000396	0.00162	CcSEcCtD
Toremifene—Angiopathy—Prednisone—multiple sclerosis	0.000389	0.0016	CcSEcCtD
Toremifene—Oedema—Triamcinolone—multiple sclerosis	0.000385	0.00158	CcSEcCtD
Toremifene—Vertigo—Betamethasone—multiple sclerosis	0.000385	0.00158	CcSEcCtD
Toremifene—Vertigo—Dexamethasone—multiple sclerosis	0.000385	0.00158	CcSEcCtD
Toremifene—Arrhythmia—Prednisone—multiple sclerosis	0.000383	0.00157	CcSEcCtD
Toremifene—Sweating—Methotrexate—multiple sclerosis	0.000383	0.00157	CcSEcCtD
Toremifene—Insomnia—Prednisolone—multiple sclerosis	0.000379	0.00156	CcSEcCtD
Toremifene—Alopecia—Prednisone—multiple sclerosis	0.000379	0.00155	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000377	0.00155	CcSEcCtD
Toremifene—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000377	0.00155	CcSEcCtD
Toremifene—Mental disorder—Prednisone—multiple sclerosis	0.000376	0.00154	CcSEcCtD
Toremifene—Nausea—Azathioprine—multiple sclerosis	0.000375	0.00154	CcSEcCtD
Toremifene—Skin disorder—Methylprednisolone—multiple sclerosis	0.000374	0.00153	CcSEcCtD
Toremifene—Malnutrition—Prednisone—multiple sclerosis	0.000373	0.00153	CcSEcCtD
Toremifene—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000373	0.00153	CcSEcCtD
Toremifene—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000372	0.00153	CcSEcCtD
Toremifene—Asthenia—Mitoxantrone—multiple sclerosis	0.000367	0.0015	CcSEcCtD
Toremifene—Pain—Prednisolone—multiple sclerosis	0.000358	0.00147	CcSEcCtD
Toremifene—Vision blurred—Prednisone—multiple sclerosis	0.000352	0.00144	CcSEcCtD
Toremifene—Oedema—Dexamethasone—multiple sclerosis	0.00035	0.00143	CcSEcCtD
Toremifene—Oedema—Betamethasone—multiple sclerosis	0.00035	0.00143	CcSEcCtD
Toremifene—Insomnia—Triamcinolone—multiple sclerosis	0.000349	0.00143	CcSEcCtD
Toremifene—Insomnia—Methylprednisolone—multiple sclerosis	0.000348	0.00143	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—multiple sclerosis	0.000345	0.00142	CcSEcCtD
Toremifene—Dyspnoea—Triamcinolone—multiple sclerosis	0.000344	0.00141	CcSEcCtD
Toremifene—Nervous system disorder—Betamethasone—multiple sclerosis	0.000343	0.00141	CcSEcCtD
Toremifene—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000343	0.00141	CcSEcCtD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000343	0.00977	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000343	0.00977	CbGpPWpGaD
Toremifene—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000342	0.0014	CcSEcCtD
Toremifene—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000342	0.0014	CcSEcCtD
Toremifene—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000338	0.00139	CcSEcCtD
Toremifene—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000338	0.00139	CcSEcCtD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000338	0.00964	CbGpPWpGaD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000338	0.00964	CbGpPWpGaD
Toremifene—Vertigo—Prednisone—multiple sclerosis	0.000335	0.00138	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—multiple sclerosis	0.000335	0.00137	CcSEcCtD
Toremifene—Anorexia—Betamethasone—multiple sclerosis	0.000333	0.00137	CcSEcCtD
Toremifene—Anorexia—Dexamethasone—multiple sclerosis	0.000333	0.00137	CcSEcCtD
Toremifene—Fatigue—Triamcinolone—multiple sclerosis	0.000332	0.00136	CcSEcCtD
Toremifene—Fatigue—Methylprednisolone—multiple sclerosis	0.000332	0.00136	CcSEcCtD
Toremifene—Pain—Triamcinolone—multiple sclerosis	0.00033	0.00135	CcSEcCtD
Toremifene—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.00033	0.0094	CbGpPWpGaD
Toremifene—Angiopathy—Methotrexate—multiple sclerosis	0.000325	0.00133	CcSEcCtD
Toremifene—Vomiting—Mitoxantrone—multiple sclerosis	0.000325	0.00133	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000323	0.00132	CcSEcCtD
Toremifene—Rash—Mitoxantrone—multiple sclerosis	0.000322	0.00132	CcSEcCtD
Toremifene—Dermatitis—Mitoxantrone—multiple sclerosis	0.000322	0.00132	CcSEcCtD
Toremifene—Chills—Methotrexate—multiple sclerosis	0.000321	0.00132	CcSEcCtD
Toremifene—Headache—Mitoxantrone—multiple sclerosis	0.00032	0.00131	CcSEcCtD
Toremifene—Alopecia—Methotrexate—multiple sclerosis	0.000317	0.0013	CcSEcCtD
Toremifene—Insomnia—Dexamethasone—multiple sclerosis	0.000316	0.0013	CcSEcCtD
Toremifene—Insomnia—Betamethasone—multiple sclerosis	0.000316	0.0013	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000316	0.00129	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—multiple sclerosis	0.000314	0.00129	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—multiple sclerosis	0.000312	0.00128	CcSEcCtD
Toremifene—Oedema—Prednisone—multiple sclerosis	0.000305	0.00125	CcSEcCtD
Toremifene—Decreased appetite—Betamethasone—multiple sclerosis	0.000304	0.00125	CcSEcCtD
Toremifene—Decreased appetite—Dexamethasone—multiple sclerosis	0.000304	0.00125	CcSEcCtD
Toremifene—Nausea—Mitoxantrone—multiple sclerosis	0.000303	0.00124	CcSEcCtD
Toremifene—ESR1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000302	0.00861	CbGpPWpGaD
Toremifene—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000302	0.00124	CcSEcCtD
Toremifene—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000302	0.00124	CcSEcCtD
Toremifene—Back pain—Methotrexate—multiple sclerosis	0.000302	0.00124	CcSEcCtD
Toremifene—Fatigue—Betamethasone—multiple sclerosis	0.000302	0.00124	CcSEcCtD
Toremifene—Fatigue—Dexamethasone—multiple sclerosis	0.000302	0.00124	CcSEcCtD
Toremifene—Pain—Betamethasone—multiple sclerosis	0.000299	0.00123	CcSEcCtD
Toremifene—Pain—Dexamethasone—multiple sclerosis	0.000299	0.00123	CcSEcCtD
Toremifene—Nervous system disorder—Prednisone—multiple sclerosis	0.000299	0.00123	CcSEcCtD
Toremifene—Skin disorder—Prednisone—multiple sclerosis	0.000296	0.00121	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisone—multiple sclerosis	0.000294	0.00121	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—multiple sclerosis	0.000294	0.00121	CcSEcCtD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000294	0.00837	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000293	0.00835	CbGpPWpGaD
Toremifene—Anorexia—Prednisone—multiple sclerosis	0.00029	0.00119	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000289	0.00825	CbGpPWpGaD
Toremifene—Vertigo—Methotrexate—multiple sclerosis	0.00028	0.00115	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—multiple sclerosis	0.000279	0.00115	CcSEcCtD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000278	0.00792	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000278	0.00792	CbGpPWpGaD
Toremifene—Dizziness—Prednisolone—multiple sclerosis	0.000277	0.00114	CcSEcCtD
Toremifene—Asthenia—Triamcinolone—multiple sclerosis	0.000277	0.00113	CcSEcCtD
Toremifene—Asthenia—Methylprednisolone—multiple sclerosis	0.000276	0.00113	CcSEcCtD
Toremifene—Insomnia—Prednisone—multiple sclerosis	0.000275	0.00113	CcSEcCtD
Toremifene—Pruritus—Triamcinolone—multiple sclerosis	0.000273	0.00112	CcSEcCtD
Toremifene—Pruritus—Methylprednisolone—multiple sclerosis	0.000272	0.00112	CcSEcCtD
Toremifene—Chest pain—Methotrexate—multiple sclerosis	0.000266	0.00109	CcSEcCtD
Toremifene—Decreased appetite—Prednisone—multiple sclerosis	0.000265	0.00109	CcSEcCtD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000264	0.00754	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000264	0.00754	CbGpPWpGaD
Toremifene—Rash—Prednisolone—multiple sclerosis	0.000264	0.00108	CcSEcCtD
Toremifene—Dermatitis—Prednisolone—multiple sclerosis	0.000264	0.00108	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000264	0.00108	CcSEcCtD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000263	0.0075	CbGpPWpGaD
Toremifene—Fatigue—Prednisone—multiple sclerosis	0.000263	0.00108	CcSEcCtD
Toremifene—Headache—Prednisolone—multiple sclerosis	0.000263	0.00108	CcSEcCtD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000261	0.00744	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000261	0.00744	CbGpPWpGaD
Toremifene—Constipation—Prednisone—multiple sclerosis	0.00026	0.00107	CcSEcCtD
Toremifene—CYP1A1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000256	0.00729	CbGpPWpGaD
Toremifene—Dizziness—Triamcinolone—multiple sclerosis	0.000255	0.00105	CcSEcCtD
Toremifene—Dizziness—Methylprednisolone—multiple sclerosis	0.000254	0.00104	CcSEcCtD
Toremifene—CYP1A1—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000252	0.00717	CbGpPWpGaD
Toremifene—Asthenia—Betamethasone—multiple sclerosis	0.000251	0.00103	CcSEcCtD
Toremifene—Asthenia—Dexamethasone—multiple sclerosis	0.000251	0.00103	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—multiple sclerosis	0.00025	0.00102	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000249	0.00102	CcSEcCtD
Toremifene—Nausea—Prednisolone—multiple sclerosis	0.000249	0.00102	CcSEcCtD
Toremifene—ESR1—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000248	0.00706	CbGpPWpGaD
Toremifene—Pruritus—Betamethasone—multiple sclerosis	0.000247	0.00102	CcSEcCtD
Toremifene—Pruritus—Dexamethasone—multiple sclerosis	0.000247	0.00102	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—multiple sclerosis	0.000247	0.00101	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000246	0.00101	CcSEcCtD
Toremifene—Vomiting—Triamcinolone—multiple sclerosis	0.000245	0.00101	CcSEcCtD
Toremifene—Vomiting—Methylprednisolone—multiple sclerosis	0.000245	0.001	CcSEcCtD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000243	0.00694	CbGpPWpGaD
Toremifene—Rash—Triamcinolone—multiple sclerosis	0.000243	0.000997	CcSEcCtD
Toremifene—Dermatitis—Triamcinolone—multiple sclerosis	0.000243	0.000996	CcSEcCtD
Toremifene—Anorexia—Methotrexate—multiple sclerosis	0.000243	0.000995	CcSEcCtD
Toremifene—Rash—Methylprednisolone—multiple sclerosis	0.000242	0.000995	CcSEcCtD
Toremifene—Dermatitis—Methylprednisolone—multiple sclerosis	0.000242	0.000994	CcSEcCtD
Toremifene—Headache—Triamcinolone—multiple sclerosis	0.000241	0.000991	CcSEcCtD
Toremifene—Headache—Methylprednisolone—multiple sclerosis	0.000241	0.000988	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000239	0.0068	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000239	0.0068	CbGpPWpGaD
Toremifene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000237	0.00676	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000231	0.0066	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000231	0.0066	CbGpPWpGaD
Toremifene—Dizziness—Betamethasone—multiple sclerosis	0.000231	0.000949	CcSEcCtD
Toremifene—Dizziness—Dexamethasone—multiple sclerosis	0.000231	0.000949	CcSEcCtD
Toremifene—Insomnia—Methotrexate—multiple sclerosis	0.00023	0.000944	CcSEcCtD
Toremifene—Nausea—Triamcinolone—multiple sclerosis	0.000229	0.000939	CcSEcCtD
Toremifene—Nausea—Methylprednisolone—multiple sclerosis	0.000228	0.000937	CcSEcCtD
Toremifene—CYP1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000228	0.0065	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000228	0.0065	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	0.000228	0.0065	CbGpPWpGaD
Toremifene—Dyspnoea—Methotrexate—multiple sclerosis	0.000227	0.000931	CcSEcCtD
Toremifene—Vomiting—Dexamethasone—multiple sclerosis	0.000222	0.000912	CcSEcCtD
Toremifene—Vomiting—Betamethasone—multiple sclerosis	0.000222	0.000912	CcSEcCtD
Toremifene—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	0.000222	0.00633	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	0.000222	0.00633	CbGpPWpGaD
Toremifene—Decreased appetite—Methotrexate—multiple sclerosis	0.000221	0.000908	CcSEcCtD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000221	0.0063	CbGpPWpGaD
Toremifene—Rash—Betamethasone—multiple sclerosis	0.000221	0.000905	CcSEcCtD
Toremifene—Rash—Dexamethasone—multiple sclerosis	0.000221	0.000905	CcSEcCtD
Toremifene—Dermatitis—Betamethasone—multiple sclerosis	0.00022	0.000904	CcSEcCtD
Toremifene—Dermatitis—Dexamethasone—multiple sclerosis	0.00022	0.000904	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00022	0.000901	CcSEcCtD
Toremifene—Fatigue—Methotrexate—multiple sclerosis	0.000219	0.0009	CcSEcCtD
Toremifene—Headache—Dexamethasone—multiple sclerosis	0.000219	0.000899	CcSEcCtD
Toremifene—Headache—Betamethasone—multiple sclerosis	0.000219	0.000899	CcSEcCtD
Toremifene—Asthenia—Prednisone—multiple sclerosis	0.000219	0.000896	CcSEcCtD
Toremifene—Pain—Methotrexate—multiple sclerosis	0.000218	0.000893	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000217	0.00619	CbGpPWpGaD
Toremifene—Pruritus—Prednisone—multiple sclerosis	0.000215	0.000884	CcSEcCtD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000214	0.00611	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000214	0.00611	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000209	0.00595	CbGpPWpGaD
Toremifene—Nausea—Betamethasone—multiple sclerosis	0.000208	0.000852	CcSEcCtD
Toremifene—Nausea—Dexamethasone—multiple sclerosis	0.000208	0.000852	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000205	0.00584	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000203	0.00579	CbGpPWpGaD
Toremifene—Dizziness—Prednisone—multiple sclerosis	0.000201	0.000826	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.000201	0.00573	CbGpPWpGaD
Toremifene—Vomiting—Prednisone—multiple sclerosis	0.000194	0.000794	CcSEcCtD
Toremifene—Rash—Prednisone—multiple sclerosis	0.000192	0.000788	CcSEcCtD
Toremifene—Dermatitis—Prednisone—multiple sclerosis	0.000192	0.000787	CcSEcCtD
Toremifene—Headache—Prednisone—multiple sclerosis	0.000191	0.000783	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000186	0.0053	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000184	0.00526	CbGpPWpGaD
Toremifene—Asthenia—Methotrexate—multiple sclerosis	0.000183	0.000749	CcSEcCtD
Toremifene—Nausea—Prednisone—multiple sclerosis	0.000181	0.000742	CcSEcCtD
Toremifene—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	0.000181	0.00515	CbGpPWpGaD
Toremifene—Pruritus—Methotrexate—multiple sclerosis	0.00018	0.000739	CcSEcCtD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000177	0.00503	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	0.000175	0.005	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000173	0.00494	CbGpPWpGaD
Toremifene—Dizziness—Methotrexate—multiple sclerosis	0.000168	0.00069	CcSEcCtD
Toremifene—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000163	0.00465	CbGpPWpGaD
Toremifene—Vomiting—Methotrexate—multiple sclerosis	0.000162	0.000664	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000161	0.0046	CbGpPWpGaD
Toremifene—Rash—Methotrexate—multiple sclerosis	0.00016	0.000658	CcSEcCtD
Toremifene—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00016	0.00457	CbGpPWpGaD
Toremifene—Dermatitis—Methotrexate—multiple sclerosis	0.00016	0.000658	CcSEcCtD
Toremifene—Headache—Methotrexate—multiple sclerosis	0.000159	0.000654	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	0.000158	0.0045	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000157	0.00447	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000154	0.00439	CbGpPWpGaD
Toremifene—Nausea—Methotrexate—multiple sclerosis	0.000151	0.00062	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.00015	0.00427	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000149	0.00424	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000148	0.00421	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000148	0.00421	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000146	0.00415	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000146	0.00415	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000143	0.00408	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000141	0.00402	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	0.00014	0.004	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—MYC—multiple sclerosis	0.000138	0.00392	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	0.000137	0.00391	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000136	0.00388	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	0.000134	0.00383	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000133	0.0038	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.00013	0.00372	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000129	0.00367	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000128	0.00364	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	0.000125	0.00357	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000124	0.00355	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000124	0.00354	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	0.000122	0.00348	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000122	0.00346	CbGpPWpGaD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000121	0.00345	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	0.000119	0.0034	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—ZNF746—multiple sclerosis	0.000119	0.0034	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000116	0.00331	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000114	0.00325	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000114	0.00325	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	0.000113	0.00323	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	0.000113	0.00322	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000112	0.0032	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000112	0.0032	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000112	0.00319	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000111	0.00316	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000111	0.00315	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.00011	0.00312	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.00011	0.00312	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PTBP1—multiple sclerosis	0.000109	0.00311	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000107	0.00305	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000107	0.00304	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000105	0.00298	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000104	0.00297	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.0001	0.00286	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9.83e-05	0.0028	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.8e-05	0.00279	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.77e-05	0.00278	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.66e-05	0.00275	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	9.54e-05	0.00272	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	9.52e-05	0.00271	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	9.5e-05	0.00271	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	9.34e-05	0.00266	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	9.32e-05	0.00266	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	9.3e-05	0.00265	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	9.16e-05	0.00261	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	9.13e-05	0.0026	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.89e-05	0.00253	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.89e-05	0.00253	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.83e-05	0.00252	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	8.64e-05	0.00246	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	8.63e-05	0.00246	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	8.62e-05	0.00246	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	8.45e-05	0.00241	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	8.3e-05	0.00236	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	8.26e-05	0.00236	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—U2AF2—multiple sclerosis	8.26e-05	0.00236	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD80—multiple sclerosis	8.15e-05	0.00232	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	8.05e-05	0.00229	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	8.05e-05	0.00229	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	8.04e-05	0.00229	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.93e-05	0.00226	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.71e-05	0.0022	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	7.71e-05	0.0022	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	7.47e-05	0.00213	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.26e-05	0.00207	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.07e-05	0.00202	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.06e-05	0.00201	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.05e-05	0.00201	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	7.01e-05	0.002	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.56e-05	0.00187	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	6.53e-05	0.00186	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.45e-05	0.00184	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.25e-05	0.00178	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	6.2e-05	0.00177	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.95e-05	0.0017	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.75e-05	0.00164	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.73e-05	0.00163	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.67e-05	0.00162	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.67e-05	0.00161	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.67e-05	0.00161	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SRM—multiple sclerosis	5.62e-05	0.0016	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.51e-05	0.00157	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.5e-05	0.00157	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.5e-05	0.00157	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.39e-05	0.00154	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	5.37e-05	0.00153	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	5.22e-05	0.00149	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—POMC—multiple sclerosis	5.2e-05	0.00148	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.13e-05	0.00146	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.13e-05	0.00146	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PABPC1—multiple sclerosis	5.06e-05	0.00144	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	5.04e-05	0.00144	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	4.93e-05	0.00141	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	4.91e-05	0.0014	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.85e-05	0.00138	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.82e-05	0.00137	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	4.7e-05	0.00134	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL5—multiple sclerosis	4.57e-05	0.0013	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GPC5—multiple sclerosis	4.57e-05	0.0013	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SRM—multiple sclerosis	4.49e-05	0.00128	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.47e-05	0.00127	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.35e-05	0.00124	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.18e-05	0.00119	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.17e-05	0.00119	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.17e-05	0.00119	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.09e-05	0.00116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RGS1—multiple sclerosis	3.99e-05	0.00114	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	3.96e-05	0.00113	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	3.96e-05	0.00113	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.89e-05	0.00111	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.87e-05	0.0011	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.84e-05	0.0011	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GPR65—multiple sclerosis	3.79e-05	0.00108	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	3.77e-05	0.00107	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPC5—multiple sclerosis	3.62e-05	0.00103	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PGR—multiple sclerosis	3.6e-05	0.00103	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SRM—multiple sclerosis	3.58e-05	0.00102	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR1—multiple sclerosis	3.46e-05	0.000987	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	3.46e-05	0.000987	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.32e-05	0.000946	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.16e-05	0.000901	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.16e-05	0.000901	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—RRM1—multiple sclerosis	3e-05	0.000855	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPC5—multiple sclerosis	2.89e-05	0.000824	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SRM—multiple sclerosis	2.76e-05	0.000788	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.56e-05	0.00073	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.52e-05	0.000719	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.52e-05	0.000719	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—VDR—multiple sclerosis	2.51e-05	0.000716	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL3—multiple sclerosis	2.47e-05	0.000703	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.47e-05	0.000703	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—RRM1—multiple sclerosis	2.4e-05	0.000683	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	2.37e-05	0.000677	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PGR—multiple sclerosis	2.34e-05	0.000667	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.33e-05	0.000663	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.31e-05	0.000658	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	2.29e-05	0.000654	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD28—multiple sclerosis	2.27e-05	0.000648	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR2—multiple sclerosis	2.23e-05	0.000636	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.21e-05	0.00063	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.2e-05	0.000628	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.16e-05	0.000616	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	2.07e-05	0.000591	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CNR1—multiple sclerosis	2.06e-05	0.000587	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.06e-05	0.000587	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2e-05	0.00057	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.95e-05	0.000555	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.95e-05	0.000555	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.91e-05	0.000545	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	1.85e-05	0.000528	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.82e-05	0.000519	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.78e-05	0.000508	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.72e-05	0.000491	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD86—multiple sclerosis	1.62e-05	0.000462	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL5—multiple sclerosis	1.6e-05	0.000455	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.48e-05	0.000423	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—multiple sclerosis	1.48e-05	0.000421	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.48e-05	0.000421	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR5—multiple sclerosis	1.44e-05	0.00041	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	1.42e-05	0.000404	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-05	0.000394	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.000392	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—multiple sclerosis	1.31e-05	0.000373	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.27e-05	0.000363	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD80—multiple sclerosis	1.18e-05	0.000337	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.16e-05	0.000331	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—multiple sclerosis	1.12e-05	0.00032	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	0.000313	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000313	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000295	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—multiple sclerosis	9.99e-06	0.000285	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TYK2—multiple sclerosis	9.98e-06	0.000285	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—multiple sclerosis	8.9e-06	0.000254	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.48e-06	0.000242	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—multiple sclerosis	8.31e-06	0.000237	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—multiple sclerosis	8.28e-06	0.000236	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—multiple sclerosis	8.12e-06	0.000231	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—multiple sclerosis	7.86e-06	0.000224	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—multiple sclerosis	7.11e-06	0.000203	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—multiple sclerosis	6.99e-06	0.000199	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—multiple sclerosis	6.61e-06	0.000188	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—multiple sclerosis	6.5e-06	0.000185	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—multiple sclerosis	6.48e-06	0.000185	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	6.48e-06	0.000185	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	6.35e-06	0.000181	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—multiple sclerosis	5.68e-06	0.000162	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—multiple sclerosis	5.17e-06	0.000147	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—multiple sclerosis	5.1e-06	0.000145	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—multiple sclerosis	4.88e-06	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—multiple sclerosis	4.38e-06	0.000125	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—multiple sclerosis	3.99e-06	0.000114	CbGpPWpGaD
